A Phase 4, Multicenter, Open-label Safety Study Of Crisaborole Ointment 2% In Children Aged 3 Months To Less Than 24 Months With Mild To Moderate Atopic Dermatitis
Phase of Trial: Phase IV
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Pfizer
- 16 Mar 2018 Status changed from not yet recruiting to recruiting.
- 19 Jan 2018 Planned initiation date changed from 18 Dec 2017 to 19 Jan 2018.
- 01 Dec 2017 New trial record